DNA clue to diabetes cancer risk

Changes to the DNA might be the reason why people with late oneset diabetes have an increase risk of cancer, it was revealed last night.

The discovery could have “profound clinical implications”, says the scientist who led the research.

It is already known that people with type 2 diabetes have a increased risk of cancers, especially blood cancers like lymphoma and leukaemia – but the new study, led by scientists at Imperial College London, UK, and CNRS in France, suggests that mutations called clonal mosaic events (CMEs) may partly explain why this is.

It is thought the mutations are a result of the development of the disease, which is often the result of lifestyle factors such as obesity.

CMEs are defects that result in some cells having extra copies or missing copies of large chunks of DNA. Although rare in young people, they become more common as we age.

About 1 in 50 people aged 70 and over have some of the mutations but it was discovered last year that people with CMEs have a 10-fold higher risk of blood cancers.

The new study, published in Nature Genetics looked for CMEs in blood samples from 7,437 people, including 2,208 people with type 2 diabetes and found that CMEs were four times more common in people with type 2 diabetes.

Lead study author Professor Philippe Froguel, of the School of Public Health at Imperial College London, said: “Type 2 diabetes is a disease that accelerates ageing, so we wondered if it would make people more likely to have these genetic defects that are associated with ageing.

“This finding may partly explain why people with type 2 diabetes are more likely to get blood cancers.

“It could have profound clinical implications. It may be useful for doctors to test for CMEs in patients with type 2 diabetes to identify those who have the highest risk of cancers. These patients would be followed up closely to watch for early signs of leukaemia and could start having mild chemotherapy.”

They also found that diabetes patients with CMEs had a much higher rate of complications such as kidney failure, eye disease or heart disease.

Bonnefond A et al. Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications, Nature Genetics. 14 July 2013.

, , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index